Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Law Offices Of Howard G. Smith Announces Class Action Lawsuit Against Abiomed Inc


Tuesday, 11 Dec 2012 03:00am EST 

Law Offices of Howard G. Smith announced that investors of Abiomed, Inc. have until January 15, 2013 to move the Court to serve as lead plaintiff in the securities fraud class action lawsuit filed in the United States District Court for the District of Massachusetts on behalf of a class (the Class) comprising all purchasers of Abiomed securities between August 5, 2011 and October 31, 2012, inclusive (the Class Period). The Complaint alleges that throughout the Class Period the defendants made materially false and misleading statements regarding the Company's business, operations and financial prospects. Specifically, defendants misrepresented and/or failed to disclose that the Company was improperly marketing and/or labeling Impella 2.5 system; the Company's financial results would be materially impacted if the Company were either forced to stop improper conduct or unable to continue improper conduct; the Company lacked adequate internal and financial controls; and as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times. 

Company Quote

25.77
0.49 +1.94%
22 Jul 2014